HUTCHMED (China) Ltd financial data

Symbol
HCM on Nasdaq, HMDCF on OTC
Industry
Pharmaceutical Preparations
Location
48 Th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong, Hong Kong
State of incorporation
Cayman Islands
Former names
Hutchison China MediTech Ltd (to 4/29/2021)
Latest financial report
20-F - Q4 2024 - Mar 19, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 872M shares +0.04%
Common Stock, Value, Issued 87.2M USD +0.04%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 154M USD -45.7%
Cash, Cash Equivalents, and Short-term Investments 836M USD -5.67%
Accounts Receivable, after Allowance for Credit Loss, Current 156M USD +33.1%
Inventory, Net 50.4M USD +0.28%
Assets, Current 1.07B USD -2.76%
Deferred Income Tax Assets, Net 12.4M USD -19.5%
Property, Plant and Equipment, Net 92.5M USD -7.25%
Operating Lease, Right-of-Use Asset 4.5M USD -3.6%
Intangible Assets, Net (Excluding Goodwill) 21K USD -75.3%
Goodwill 2.99M USD -2.42%
Other Assets, Noncurrent 15.4M USD +5.17%
Assets 1.27B USD -0.44%
Accounts Payable, Current 42.5M USD +17.1%
Employee-related Liabilities, Current 29.8M USD -34%
Contract with Customer, Liability, Current 50.1M USD -13.1%
Liabilities, Current 377M USD -6.57%
Contract with Customer, Liability, Noncurrent 97.2M USD
Deferred Income Tax Liabilities, Net 2.99M USD +101%
Operating Lease, Liability, Noncurrent 4.09M USD +43%
Other Liabilities, Noncurrent 10.8M USD -4.5%
Liabilities 502M USD -6.35%
Accumulated Other Comprehensive Income (Loss), Net of Tax -11.6M USD -41.9%
Retained Earnings (Accumulated Deficit) -833M USD +4.33%
Stockholders' Equity Attributable to Parent 760M USD +4.02%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 772M USD +3.83%
Liabilities and Equity 1.27B USD -0.44%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 1.5B shares 0%
Common Stock, Shares, Issued 872M shares +0.04%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 154M USD -45.7%
Deferred Tax Assets, Valuation Allowance 299M USD +5.58%
Deferred Tax Assets, Gross 312M USD +4.28%
Operating Lease, Liability 7.01M USD +3.35%
Lessee, Operating Lease, Liability, to be Paid 7.29M USD +4.53%
Property, Plant and Equipment, Gross 152M USD +3.77%
Operating Lease, Liability, Current 2.93M USD -25.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.71M USD +127%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.1M USD -23.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 277K USD +47.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.27M USD +38.1%
Deferred Tax Assets, Operating Loss Carryforwards 298M USD +4.75%
Lessee, Operating Lease, Liability, to be Paid, Year Four 174K USD -75.1%
Deferred Tax Assets, Net of Valuation Allowance 12.4M USD -19.5%